本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

7.46
+0.18002.47%
盘后7.460.00000.00%16:10 EDT
成交量:4.92万
成交额:36.30万
市值:4,561.64万
市盈率:-0.44
高:7.96
开:7.21
低:7.01
收:7.28
数据加载中...
2022/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/06

重要事件披露

8-K - Current report
2021/11/18

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/11/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/24

重要事件披露

8-K - Current report
2021/06/24

重要事件披露

8-K/A [Amend] - Current report